Hamman-Rich syndrome epidemiology and demographics

	Hamman-Rich syndrome Microchapters
Home
Patient Information
Overview
Historical Perspective
Classification
Pathophysiology
Causes
Differentiating Hamman-Rich syndrome from other Diseases
Epidemiology and Demographics
Risk Factors
Natural History, Complications and Prognosis
Diagnosis
History and Symptoms
Physical Examination
Laboratory Findings
Electrocardiogram
Chest X Ray
CT
MRI
Echocardiography or Ultrasound
Other Imaging Findings
Other Diagnostic Studies
Treatment
Medical Therapy
Surgery
Primary Prevention
Secondary Prevention
Cost-Effectiveness of Therapy
Future or Investigational Therapies
Case Studies
Case #1
Hamman-Rich syndrome epidemiology and demographics On the Web
Most recent articles
Most cited articles
Review articles
CME Programs
Powerpoint slides
Images
American Roentgen Ray Society Images of Hamman-Rich syndrome epidemiology and demographics All Images X-rays Echo & Ultrasound CT Images MRI
Ongoing Trials at Clinical Trials.gov
US National Guidelines Clearinghouse
NICE Guidance
FDA on Hamman-Rich syndrome epidemiology and demographics
CDC on Hamman-Rich syndrome epidemiology and demographics
Hamman-Rich syndrome epidemiology and demographics in the news
Blogs on Hamman-Rich syndrome epidemiology and demographics
Directions to Hospitals Treating Hamman-Rich syndrome
Risk calculators and risk factors for Hamman-Rich syndrome epidemiology and demographics

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Chandrakala Yannam, MD [2]

Overview

The incidence/prevalence of [disease name] is approximately [number range] per 100,000 individuals worldwide.
In [year], the incidence/prevalence of [disease name] was estimated to be [number range] cases per 100,000 individuals worldwide.

The incidence/prevalence of [disease name] is approximately [number range] per 100,000 individuals worldwide.
In [year], the incidence/prevalence of [disease name] was estimated to be [number range] cases per 100,000 individuals worldwide.
The prevalence of [disease/malignancy] is estimated to be [number] cases annually.

The case-fatality rate/mortality rate of acute interstitial pneumonitis is approximately 12500 per 100000 among in-hospital patients.^[1]
The mean time from symptom onset to death was approximately 26-34 days.

Acute interstitial pneumonitis occur typically previously healthy individuals in the age group of 50 to 55years.^[2]

There is insufficient evidence to support the regional distribution of acute interstitial pneumonitis.

↑ Quefatieh A, Stone CH, DiGiovine B, Toews GB, Hyzy RC (August 2003). "Low hospital mortality in patients with acute interstitial pneumonia". Chest. 124 (2): 554–9. PMID 12907542.
↑ Vourlekis JS, Brown KK, Cool CD, Young DA, Cherniack RM, King TE, Schwarz MI (November 2000). "Acute interstitial pneumonitis. Case series and review of the literature". Medicine (Baltimore). 79 (6): 369–78. PMID 11144035.